Amid Ukraine-Russia crisis, our analysts and industry experts are closely monitoring the markets and working hard to identify, gather and timely deliver analysis of the impact of the situation and the impact that it has on various markets. All our reports are updated with the latest impact on the market before being sent out to our customers.

Global Cardiovascular Stents Market: By Procedure Type: Coronary Stenting, Peripheral Stenting; By Stent Type: Drug Eluting Stents (DES), Others; By Material; By Disease Indication; By End-User; Regional Analysis; Historical Market and Forecast (2018-2028); Market Dynamics; Competitive Landscape; Industry Events and Developments

Global Cardiovascular Stents Market Outlook

The global cardiovascular stents market reached a value of about USD 12.8 billion in 2021. The industry is further expected to grow at a CAGR of about 4.80% in the forecast period of 2023-2028 to reach a value of around USD 16.18 billion by 2027.

 

Global Cardiovascular Stents Market

Read more about this report - REQUEST FREE SAMPLE COPY IN PDF

 

North America to be a Significant Regional Market for Cardiovascular Stents

North America dominates the market for cardiovascular stents due to the growing prevalence. An improving level of healthcare infrastructure, coupled with the increased research and development proficiencies, has fostered the development of the industry in this region. A sedentary lifestyle results in obesity and other cardiovascular diseases, such as heart attack, stroke, and ischemic heart diseases (IHD), primarily driving the market growth in North America. In addition, various technological advancements in cardiovascular stent technologies, such as bifurcated stents and biodegradable materials, have further aided the market growth.

The Asia Pacific region, on the contrary, will exhibit the highest growth rate during the forecast period due to the rise in angioplasty surgeries in this region. Rising diabetic patients and bad lifestyle choices, such as drinking and smoking, have bolstered the market growth. The market is driven by the rising ageing population with cardiovascular disease, improving healthcare infrastructure in developing economies, rising PCI procedures, growing healthcare awareness, improved reimbursement scenario, and low manufacturing cost of coronary stents in this region.

 

Market Segmentations

In order to reopen a blocked or narrowed coronary artery, a cardiovascular stent is used. These stents are also utilised to help the heart's blood flow. It also lowers the chance of a heart attack or heat stroke, enhancing a person's quality of life.

 

Global Cardiovascular Stents Market by Segments

Read more about this report - REQUEST FREE SAMPLE COPY IN PDF

 

Based on procedure type, the market includes:

  • Coronary Stenting
  • Peripheral Stenting

By stent type, the market is segmented into:

  • Drug-Eluting Stents (DES)
  • Bioresorbable Stents
  • Bare Metal Stents
  • Dual Therapy Stent
  • Others

The various materials in the market are:

  • Stainless Steel
  • Cobalt-Chromium
  • Nitinol
  • Polymers

Based on disease indication, the market is divided into:

  • Venous Diseases
  • Arterial Diseases

The end-users of the market are:

  • Hospitals
  • Ambulatory Surgery Centres
  • Speciality Clinics
  • Catheterisation Labs

The regional markets for the cardiovascular stents industry can be divided into North America, Europe, the Asia Pacific, Latin America, the Middle East and Africa.

 

Global Cardiovascular Stents Market by Region

Read more about this report - REQUEST FREE SAMPLE COPY IN PDF

 

Rising Prevalence of Cardiovascular Diseases Augmenting the Market Growth

The rising prevalence of cardiovascular diseases (CVDs), like stroke and heart attack, and the rising geriatric population at higher risk of cardiac diseases are expected to propel the demand for cardiovascular stents over the forecast period. The low rate of risks involved, and the low cost of manufacturing have also pushed the demand for cardiovascular stents. Another factor projected to drive the utilisation of cardiovascular stents throughout the forecast period is the growing preference for minimally invasive surgeries (MIS). These procedures have the advantage of having tiny incision wounds, which leads to increased patient satisfaction. These procedures also result in shorter hospital stays and faster recovery times. Technological advances in cardiovascular stents, such as the invention of bifurcation stents and biodegradable materials, have led to more effective and improved CVD treatment outcomes. Companies are actively involved in product developments, partnerships, and strategic collaborations. The factors mentioned are likely to boost the market for cardiovascular stents forward in the coming years. Additionally, an increase in funding from private and government organisations for the development of the healthcare sector and research centres; and a rise in demand for drug-eluting stents are also expected to propel the market growth globally.

 

Key Players in the Global Cardiovascular Stents Market

The report gives a detailed analysis of the following key players in the global cardiovascular stents industry, covering their competitive landscape, capacity, and latest developments like mergers, acquisitions, and investments, expansions of capacity, and plant turnarounds:

  • Cordis US Corp
  • BIOTRONIK SE & Co KG
  • MicroPort Scientific Corporation
  • Abbott Laboratories
  • Boston Scientific Corporation (BSC)
  • Medtronic Plc
  • Others

The comprehensive EMR report provides an in-depth assessment of the market based on the Porter's five forces model along with giving a SWOT analysis.

 

Key Highlights of the Report

REPORT FEATURES DETAILS
Base Year 2022
Historical Period 2018-2022
Forecast Period 2023-2028
Scope of the Report

Historical and Forecast Trends, Industry Drivers and Constraints, Historical and Forecast Market Analysis by Segment:

  • Procedure Type
  • Stent Type
  • Material
  • Disease Indication
  • End-User
  • Region
Breakup by Procedure Type
  • Coronary Stenting
  • Peripheral Stenting
Breakup by Stent Type
  • Drug-Eluting Stents (DES)
  • Bioresorbable Stents
  • Bare Metal Stents
  • Dual Therapy Stent
  • Others
Breakup by Material
  • Stainless Steel
  • Cobalt-Chromium
  • Nitinol
  • Polymers
Breakup by Disease Indication
  • Venous Diseases
  • Arterial Diseases
Breakup by End-User
  • Hospitals
  • Ambulatory Surgery Centres
  • Speciality Clinics
  • Catheterisation Labs
Breakup by Region
  • North America
    • United States of America 
    • Canada
  • Europe
    • United Kingdom
    • Germany
    • France
    • Italy
    • Others
  • Asia Pacific
    • China
    • Japan
    • India
    • ASEAN
    • Australia
    • Others
  • Latin America
    • Brazil
    • Argentina
    • Mexico
    • Others
  • Middle East and Africa
    • Saudi Arabia
    • United Arab Emirates
    • Nigeria
    • South Africa
    • Others
Market Dynamics
  • SWOT
  • Porter's Five Forces
  • Key Indicators for Demand
  • Key Indicators for Price
Competitive Landscape
  • Market Structure
  • Company Profiles
    • Company Overview
    • Product Portfolio
    • Demographic Reach and Achievements
    • Certifications
Companies Covered
  • Cordis US Corp
  • BIOTRONIK SE & Co KG
  • MicroPort Scientific Corporation
  • Abbott Laboratories
  • Boston Scientific Corporation (BSC)
  • Medtronic Plc
  • Others
Report Price and Purchase Option Explore our purchase options that are best suited to your resources and industry needs.
Delivery Format Delivered as an attached PDF and Excel through email, with an option of receiving an editable PPT, according to the purchase option.

 

*At Expert Market Research, we strive to always give you current and accurate information. The numbers depicted in the description are indicative and may differ from the actual numbers in the final EMR report.

1    Preface 
2    Report Coverage – Key Segmentation and Scope
3    Report Description

    3.1    Market Definition and Outlook
    3.2    Properties and Applications
    3.3    Market Analysis
    3.4    Key Players
4    Key Assumptions   
5    Executive Summary

    5.1    Overview
    5.2    Key Drivers
    5.3    Key Developments  
    5.4    Competitive Structure
    5.5    Key Industrial Trends
6    Market Snapshot
    6.1    Global
    6.2    Region
7    Opportunities and Challenges in the Market
8    Global Cardiovascular Stents Market Analysis

    8.1    Key Industry Highlights
    8.2    Global Cardiovascular Stents Historical Market (2018-2022) 
    8.3    Global Cardiovascular Stents Market Forecast (2023-2028)
    8.4    Global Cardiovascular Stents Market by Procedure Type
        8.4.1    Coronary Stenting
            8.4.1.1    Market Share
            8.4.1.2    Historical Trend (2018-2022)
            8.4.1.3    Forecast Trend (2023-2028)
        8.4.2    Peripheral Stenting
            8.4.2.1    Market Share
            8.4.2.2    Historical Trend (2018-2022)
            8.4.2.3    Forecast Trend (2023-2028)
    8.5    Global Cardiovascular Stents Market by Stent Type
        8.5.1    Drug Eluting Stents (DES)
            8.5.1.1    Market Share
            8.5.1.2    Historical Trend (2018-2022)
            8.5.1.3    Forecast Trend (2023-2028)
        8.5.2    Bioresorbable Stents
            8.5.2.1    Market Share
            8.5.2.2    Historical Trend (2018-2022)
            8.5.2.3    Forecast Trend (2023-2028)
        8.5.3    Bare Metal Stents
            8.5.3.1    Market Share
            8.5.3.2    Historical Trend (2018-2022)
            8.5.3.3    Forecast Trend (2023-2028)
        8.5.4    Dual Therapy Stent 
            8.5.4.1    Market Share
            8.5.4.2    Historical Trend (2018-2022)
            8.5.4.3    Forecast Trend (2023-2028)
        8.5.5    Others
    8.6    Global Cardiovascular Stents Market by Material
        8.6.1    Stainless Steel 
            8.6.1.1    Market Share
            8.6.1.2    Historical Trend (2018-2022)
            8.6.1.3    Forecast Trend (2023-2028)
        8.6.2    Cobalt Chromium
            8.6.2.1    Market Share
            8.6.2.2    Historical Trend (2018-2022)
            8.6.2.3    Forecast Trend (2023-2028)
        8.6.3    Nitinol
            8.6.3.1    Market Share
            8.6.3.2    Historical Trend (2018-2022)
            8.6.3.3    Forecast Trend (2023-2028)
        8.6.4    Polymers 
            8.6.4.1    Market Share
            8.6.4.2    Historical Trend (2018-2022)
            8.6.4.3    Forecast Trend (2023-2028)
    8.7    Global Cardiovascular Stents Market by Disease Indication
        8.7.1    Venous Diseases
            8.7.1.1    Market Share
            8.7.1.2    Historical Trend (2018-2022)
            8.7.1.3    Forecast Trend (2023-2028)
        8.7.2    Arterial Diseases
            8.7.2.1    Market Share
            8.7.2.2    Historical Trend (2018-2022)
            8.7.2.3    Forecast Trend (2023-2028)
    8.8    Global Cardiovascular Stents Market by End-User
        8.8.1    Hospitals
            8.8.1.1    Market Share
            8.8.1.2    Historical Trend (2018-2022)
            8.8.1.3    Forecast Trend (2023-2028)
        8.8.2    Ambulatory Surgery Centres
            8.8.2.1    Market Share
            8.8.2.2    Historical Trend (2018-2022)
            8.8.2.3    Forecast Trend (2023-2028)
        8.8.3    Speciality Clinics
            8.8.3.1    Market Share
            8.8.3.2    Historical Trend (2018-2022)
            8.8.3.3    Forecast Trend (2023-2028)
        8.8.4    Catheterisation Labs
            8.8.4.1    Market Share
            8.8.4.2    Historical Trend (2018-2022)
            8.8.4.3    Forecast Trend (2023-2028)    
    8.9    Global Cardiovascular Stents Market by Region
        8.9.1    North America
            8.9.1.1    Market Share
            8.9.1.2    Historical Trend (2018-2022) 
            8.9.1.3    Forecast Trend (2023-2028)
        8.9.2    Europe
            8.9.2.1    Market Share
            8.9.2.2    Historical Trend (2018-2022) 
            8.9.2.3    Forecast Trend (2023-2028)
        8.9.3    Asia Pacific
            8.9.3.1    Market Share
            8.9.3.2    Historical Trend (2018-2022) 
            8.9.3.3    Forecast Trend (2023-2028)
        8.9.4    Latin America
            8.9.4.1    Market Share
            8.9.4.2    Historical Trend (2018-2022) 
            8.9.4.3    Forecast Trend (2023-2028)
        8.9.5    Middle East and Africa
            8.9.5.1    Market Share
            8.9.5.2    Historical Trend (2018-2022) 
            8.9.5.3    Forecast Trend (2023-2028)
9    North America Cardiovascular Stents Market Analysis
    9.1    United States of America 
        9.1.1    Market Share
        9.1.2    Historical Trend (2018-2022) 
        9.1.3    Forecast Trend (2023-2028)
    9.2    Canada
        9.2.1    Market Share
        9.2.2    Historical Trend (2018-2022) 
        9.2.3    Forecast Trend (2023-2028)
10    Europe Cardiovascular Stents Market Analysis
    10.1    United Kingdom
        10.1.1    Market Share
        10.1.2    Historical Trend (2018-2022) 
        10.1.3    Forecast Trend (2023-2028)
    10.2    Germany
        10.2.1    Market Share
        10.2.2    Historical Trend (2018-2022) 
        10.2.3    Forecast Trend (2023-2028)
    10.3    France
        10.3.1    Market Share
        10.3.2    Historical Trend (2018-2022) 
        10.3.3    Forecast Trend (2023-2028)
    10.4    Italy
        10.4.1    Market Share
        10.4.2    Historical Trend (2018-2022) 
        10.4.3    Forecast Trend (2023-2028)
    10.5    Others
11    Asia Pacific Cardiovascular Stents Market Analysis
    11.1    China
        11.1.1    Market Share
        11.1.2    Historical Trend (2018-2022) 
        11.1.3    Forecast Trend (2023-2028)
    11.2    Japan
        11.2.1    Market Share
        11.2.2    Historical Trend (2018-2022) 
        11.2.3    Forecast Trend (2023-2028)
    11.3    India
        11.3.1    Market Share
        11.3.2    Historical Trend (2018-2022) 
        11.3.3    Forecast Trend (2023-2028)
    11.4    ASEAN
        11.4.1    Market Share
        11.4.2    Historical Trend (2018-2022) 
        11.4.3    Forecast Trend (2023-2028)
    11.5    Australia
        11.5.1    Market Share
        11.5.2    Historical Trend (2018-2022) 
        11.5.3    Forecast Trend (2023-2028)
    11.6    Others
12    Latin  America Cardiovascular Stents Market Analysis
    12.1    Brazil
        12.1.1    Market Share
        12.1.2    Historical Trend (2018-2022) 
        12.1.3    Forecast Trend (2023-2028)
    12.2    Argentina
        12.2.1    Market Share
        12.2.2    Historical Trend (2018-2022) 
        12.2.3    Forecast Trend (2023-2028)
    12.3    Mexico
        12.3.1    Market Share
        12.3.2    Historical Trend (2018-2022) 
        12.3.3    Forecast Trend (2023-2028)
    12.4    Others
13    Middle East and Africa Cardiovascular Stents Market Analysis
    13.1    Saudi Arabia
        13.1.1    Market Share
        13.1.2    Historical Trend (2018-2022) 
        13.1.3    Forecast Trend (2023-2028)
    13.2    United Arab Emirates
        13.2.1    Market Share
        13.2.2    Historical Trend (2018-2022) 
        13.2.3    Forecast Trend (2023-2028)
    13.3    Nigeria
        13.3.1    Market Share
        13.3.2    Historical Trend (2018-2022) 
        13.3.3    Forecast Trend (2023-2028)
    13.4    South Africa
        13.4.1    Market Share
        13.4.2    Historical Trend (2018-2022) 
        13.4.3    Forecast Trend (2023-2028)
    13.5    Others
14    Market Dynamics
    14.1    SWOT Analysis
        14.1.1    Strengths
        14.1.2    Weaknesses
        14.1.3    Opportunities
        14.1.4    Threats
    14.2    Porter’s Five Forces Analysis
        14.2.1    Supplier’s Power
        14.2.2    Buyer’s Power
        14.2.3    Threat of New Entrants
        14.2.4    Degree of Rivalry
        14.2.5    Threat of Substitutes
    14.3    Key Indicators for Demand
    14.4    Key Indicators for Price
15    Value Chain Analysis
16    Competitive Landscape

    16.1    Market Structure
    16.2    Company Profiles
        16.2.1     Cordis US Corp
            16.2.1.1    Company Overview
            16.2.1.2    Product Portfolio
            16.2.1.3    Demographic Reach and Achievements
            16.2.1.4    Certifications
        16.2.2    BIOTRONIK SE & Co KG
            16.2.2.1    Company Overview
            16.2.2.2    Product Portfolio
            16.2.2.3    Demographic Reach and Achievements
            16.2.2.4    Certifications
        16.2.3    MicroPort Scientific Corporation
            16.2.3.1    Company Overview
            16.2.3.2    Product Portfolio
            16.2.3.3    Demographic Reach and Achievements
            16.2.3.4    Certifications
        16.2.4    Abbott Laboratories
            16.2.4.1    Company Overview
            16.2.4.2    Product Portfolio
            16.2.4.3    Demographic Reach and Achievements
            16.2.4.4    Certifications
            16.2.3.4    Certifications
        16.2.5    Boston Scientific Corporation (BSC)
            16.2.5.1    Company Overview
            16.2.5.2    Product Portfolio
            16.2.5.3    Demographic Reach and Achievements
            16.2.5.4    Certifications
        16.2.6    Medtronic Plc
            16.2.6.1    Company Overview
            16.2.6.2    Product Portfolio
            16.2.6.3    Demographic Reach and Achievements
            16.2.6.4    Certifications
        16.2.7    Others
17    Key Trends and Developments in the Market

 

List of Key Figures and Tables

1.    Global Cardiovascular Stents Market: Key Industry Highlights, 2018 and 2028
2.    Global Cardiovascular Stents Historical Market: Breakup by Procedure Type (USD Billion), 2018-2022
3.    Global Cardiovascular Stents Market Forecast: Breakup by Procedure Type (USD Billion), 2023-2028
4.    Global Cardiovascular Stents Historical Market: Breakup by Stent Type (USD Billion), 2018-2022
5.    Global Cardiovascular Stents Market Forecast: Breakup by Stent Type (USD Billion), 2023-2028
6.    Global Cardiovascular Stents Historical Market: Breakup by Material (USD Billion), 2018-2022
7.    Global Cardiovascular Stents Market Forecast: Breakup by Material (USD Billion), 2023-2028
8.    Global Cardiovascular Stents Historical Market: Breakup by Disease Indication (USD Billion), 2018-2022
9.    Global Cardiovascular Stents Market Forecast: Breakup by Disease Indication (USD Billion), 2023-2028
10.    Global Cardiovascular Stents Historical Market: Breakup by End-User (USD Billion), 2018-2022
11.    Global Cardiovascular Stents Market Forecast: Breakup by End-User (USD Billion), 2023-2028
12.    Global Cardiovascular Stents Historical Market: Breakup by Region (USD Billion), 2018-2022
13.    Global Cardiovascular Stents Market Forecast: Breakup by Region (USD Billion), 2023-2028
14.    North America Cardiovascular Stents Historical Market: Breakup by Country (USD Billion), 2018-2022
15.    North America Cardiovascular Stents Market Forecast: Breakup by Country (USD Billion), 2023-2028
16.    Europe Cardiovascular Stents Historical Market: Breakup by Country (USD Billion), 2018-2022
17.    Europe Cardiovascular Stents Market Forecast: Breakup by Country (USD Billion), 2023-2028
18.    Asia Pacific Cardiovascular Stents Historical Market: Breakup by Country (USD Billion), 2018-2022
19.    Asia Pacific Cardiovascular Stents Market Forecast: Breakup by Country (USD Billion), 2023-2028
20.    Latin America Cardiovascular Stents Historical Market: Breakup by Country (USD Billion), 2018-2022
21.    Latin America Cardiovascular Stents Market Forecast: Breakup by Country (USD Billion), 2023-2028
22.    Middle East and Africa Cardiovascular Stents Historical Market: Breakup by Country (USD Billion), 2018-2022
23.    Middle East and Africa Cardiovascular Stents Market Forecast: Breakup by Country (USD Billion), 2023-2028
24.    Global Cardiovascular Stents Market Structure.

Key Questions Answered in the Report

In 2021, the global cardiovascular stents market attained a value of nearly USD 12.8 billion.

The market is projected to grow at a CAGR of 4.80% between 2023 and 2028.

The market is estimated to witness healthy growth in the forecast period of 2023-2028 to reach USD 16.18 billion by 2027.

The major drivers of the market include the increased research and development activities, rising angioplasty surgeries, rising diabetic patients, growing healthcare awareness, low cost of manufacturing, increasing preference for minimally invasive surgeries (MIS), technological advances, increase in funding from private and government organisations, and a rise in demand for drug-eluting stents.

The rising prevalence of cardiovascular diseases (CVDs) and the growing geriatric population are the key industry trends propelling the market's growth.

The major regions in the industry are North America, Latin America, the Middle East and Africa, Europe, and the Asia Pacific.

Based on procedure type, the market includes coronary stenting and peripheral stenting.

The major stent types are drug-eluting stents (DES), bioresorbable stents, bare-metal stents, and dual therapy stents.

The various materials in the market are stainless steel, cobalt-chromium, nitinol, and polymers.

The market is divided into venous and arterial diseases based on disease indication.

The end-users of the market are hospitals, ambulatory surgery centres, speciality clinics, and catheterisation labs.

The major players in the industry are Cordis US Corp, BIOTRONIK SE & Co KG, MicroPort Scientific Corporation, Abbott Laboratories, Boston Scientific Corporation (BSC), and Medtronic Plc, among others.

Analyst Review

The global cardiovascular stents market attained a value of USD 12.8 billion in 2021, driven by the increasing prevalence of cardiovascular diseases (CVDs). Aided by the growing healthcare awareness and geriatric population, the market is expected to witness further growth in the forecast period of 2023-2028, growing at a CAGR of 4.80%. The market is projected to reach USD 16.18 billion by 2027.

EMR’s meticulous research methodology delves deep into the market, covering the macro and micro aspects of the industry. Based on procedure type, the market includes coronary stenting and peripheral stenting. The major stent types are drug-eluting stents (DES), bioresorbable stents, bare-metal stents, and dual therapy stents, among others. The various materials in the market are stainless steel, cobalt-chromium, nitinol, and polymers. Based on disease indication, the market is divided into venous diseases and arterial diseases. The end-users of the market are hospitals, ambulatory surgery centres, speciality clinics, and catheterisation labs. The major regional markets for cardiovascular stents are North America, Europe, the Asia Pacific, Latin America, the Middle East and Africa. The key players in the cardiovascular stents market are Cordis US Corp, BIOTRONIK SE & Co KG, MicroPort Scientific Corporation, Abbott Laboratories, Boston Scientific Corporation (BSC), and Medtronic Plc, among others.

EMR’s research methodology uses a combination of cutting-edge analytical tools and the expertise of their highly accomplished team, thus, providing their customers with market insights that are accurate, actionable, and help them remain ahead of their competition.

Purchase Full Report

Mini Report

$1499
  • Selected Sections, One User
  • Printing Not Allowed
  • Email Delivery in PDF
  • Free Limited Customisation
  • Post Sales Analyst Support
  • 50% Discount on Next Update

Single User License

$2699
  • All Sections, One User
  • One Print Allowed
  • Email Delivery in PDF
  • Free Limited Customisation
  • Post Sales Analyst Support
  • 50% Discount on Next Update

Five User License

$3699
  • All Sections, Five Users
  • Five Prints Allowed
  • Email Delivery in PDF
  • Free Limited Customisation
  • Post Sales Analyst Support
  • 50% Discount on Next Update

Corporate License

$4699
  • All Sections, Unlimited Users
  • Unlimited Prints Allowed
  • Email Delivery in PDF + Excel
  • Free Limited Customisation
  • Post Sales Analyst Support
  • 50% Discount on Next Update

Any Question? Speak With An Analyst

Contact Analyst

View A Sample

Request Sample

Did You Miss Anything, Ask Now

Request Customisation
Why Expert Market Research?

Right People

We are technically excellent, strategic, practical, experienced and efficient; our analysts are hand-picked based on having the right attributes to work successfully and execute projects based on your expectations.

Right Methodology

We leverage our cutting-edge technology, our access to trusted databases, and our knowledge of the current models used in the market to deliver you research solutions that are tailored to your needs and put you ahead of the curve.

Right Price

We deliver in-depth and superior quality research in prices that are reasonable, unmatchable, and shows our understanding of your resource structure. We, additionally, offer attractive discounts on our upcoming reports.

Right Support

Our team of expert analysts are at your beck and call to deliver you optimum results that are customised to meet your precise needs within the specified timeframe and help you form a better understanding of the industry.

NEWSLETTER